Aubrai Ignition Sale Oversubscribed by 6 Times
Foresight News reports that Bio Protocol has announced that the Ignition Sale public offering for the biotechnology project Aubrai was oversubscribed by six times within just a few hours of its launch.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Oil and gas equipment manufacturer VME Companies (VME.US) sets IPO price at $4-$5 per share, plans to raise $18 million
VME Companies, a supplier of offshore oil and gas facility process modules and separation equipment, announced the terms of its IPO on Tuesday.
Wall Street veteran who warned of previous financial crises sounds the bubble alarm: US stock valuations, leverage, and positions are at their most extreme levels in 40 years of industry experience.
David Rosenberg has warned that this is the most tense market in his 40-year career.
Japanese stocks closed down 0.05%, marking five consecutive losses.
Morgan Stanley raises Unity's target price to $55
Crypto prices
More
